blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2091928

EP2091928 - 3-(2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.07.2012
Database last updated on 15.06.2024
Most recent event   Tooltip13.07.2012Application deemed to be withdrawnpublished on 15.08.2012  [2012/33]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [2009/35]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis IN 46285 / US
Inventor(s)01 / DURHAM, Timothy Barrett
4651 Sundance Trail
Indianapolis, IN 46239 / US
02 / HAHN, Patric James
7418 Nutmeg Court
Indianapolis, IN 46237 / US
03 / KOHN, Todd Jonathan
818 North Delaware Street
Unit 412, San Mateo, California 94401 / US
04 / MCCARTHY, James Ray
4037 Oakleaf Drive
Zionsville, IN 46077 / US
05 / BROUGHTON, Howard Barff Lilly S.A.
Avenida de la Industria 30
E-28108 Alcobendas / ES
06 / DALLY, Robert Dean
10914 Perry Pear Drive
Zionsville, IN 46077 / US
07 / GONZALEZ-GARCIA, Maria Rosario Lilly S.A.
Avenida de la Industria 30
E-28108 Alcobendas / ES
08 / HENRY, Kenneth James Jr
10917 Trumbull Circle
Carmel, Indiana 46032 / US
09 / SHEPHERD, Timothy Alan
8705 Country Woods Court
Indianpolis, IN 46217 / US
10 / ERICKSON, Jon André
1540 White Ash Drive
Carmel, IN 46033 / US
11 / BUENO-MELENDO, Ana Belén Lilly S.A.
Avenida de la Industria 30
E-28108 Alcobendas / ES
 [2009/35]
Representative(s)Suarez-Miles, Ana Sanchiz, et al
Eli Lilly and Company Limited
European Patent Operations
Lilly Research Centre, Erl Wood Manor
Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
[N/P]
Former [2009/35]Suarez-Miles, Ana Sanchiz, et al
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date05798832.120.09.2005
[2009/35]
WO2005US33277
Priority number, dateUS20040611718P21.09.2004         Original published format: US 611718 P
US20050696949P06.07.2005         Original published format: US 696949 P
[2009/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006034093
Date:30.03.2006
Language:EN
[2006/13]
Type: A2 Application without search report 
No.:EP2091928
Date:26.08.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 30.03.2006 takes the place of the publication of the European patent application.
[2009/35]
Search report(s)International search report - published on:EP13.07.2006
ClassificationIPC:C07D265/30, C07D265/32, A61K31/5375, A61K31/5377, C07D413/12, C07C217/48, C07C271/20, C07F7/18
[2009/35]
CPC:
C07C271/20 (EP,US); A61P25/28 (EP); A61P43/00 (EP);
C07C233/36 (EP,US); C07D265/30 (EP,US); C07D265/32 (EP,US);
C07D413/12 (EP,US); C07F7/1804 (EP,US); C07C2601/08 (EP,US);
C07C2601/14 (EP,US); C07C2601/18 (EP,US); C07C2603/74 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/35]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:3-(2-ACYLAMINO-1-HYDROXYETHYL)MORPHOLINDERIVATE UND IHRE VERWENDUNG ALS BACE-INHIBITOREN[2009/35]
English:3-(2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS[2009/35]
French:DÉRIVÉS de la 3-(2-ACYLAMINO-1-HYDROXYETHYL)- MORPHOLINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS de la B.A.C.E.[2009/35]
Entry into regional phase23.04.2007National basic fee paid 
23.04.2007Designation fee(s) paid 
23.04.2007Examination fee paid 
Examination procedure19.03.2007Amendment by applicant (claims and/or description)
23.04.2007Examination requested  [2009/35]
06.10.2011Despatch of a communication from the examining division (Time limit: M04)
17.02.2012Application deemed to be withdrawn, date of legal effect  [2012/33]
22.03.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/33]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.10.2011
Fees paidRenewal fee
01.10.2007Renewal fee patent year 03
30.09.2008Renewal fee patent year 04
30.09.2009Renewal fee patent year 05
30.09.2010Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.201107   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2004043916  (MERCK & CO INC [US], et al) [A] 1-11 * the whole document *;
 [A]WO03006021  (ELAN PHARM INC [US], et al) [A] 1-11 * the whole document *;
 [PA]WO2005016876  (SCHERING CORP [US], et al) [PA] 1-11;
 [X]  - SCHOLZ, DIETER ET AL, "Backbone stabilized peptidomimetics containing statine-like structural elements: diastereospecific synthesis of trisubstituted cyclic ureas and 1,4-diazepan-2-ones", MONATSHEFTE FUER CHEMIE , 130(10), 1283-1300 CODEN: MOCMB7; ISSN: 0026-9247, (1999), XP002371889 [X] 9 * page 1295, paragraph L *

DOI:   http://dx.doi.org/10.1007/PL00010189
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.